Lincocin 600 mg/2 ml inj. sol. i.v. vial

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ixtrih issa

Ingredjent attiv:

Lincomycin Hydrochloride - Eq. Lincomycin 300 mg/ml

Disponibbli minn:

Pfizer SA-NV

Kodiċi ATC:

J01FF02

INN (Isem Internazzjonali):

Lincomycin Hydrochloride

Dożaġġ:

300 mg/ml

Għamla farmaċewtika:

Solution for injection

Kompożizzjoni:

Lincomycin Hydrochloride

Rotta amministrattiva:

Intravenous use

Żona terapewtika:

Lincomycin

Sommarju tal-prodott:

CTI code: 061643-08 - Pack size: 100 x 10 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 061643-07 - Pack size: 25 x 10 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 061643-06 - Pack size: 10 x 10 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 061643-05 - Pack size: 6 x 10 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 061643-04 - Pack size: 5 x 10 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 061643-03 - Pack size: 3 x 10 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 061643-02 - Pack size: 2 x 10 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 061643-01 - Pack size: 10 ml - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: No

Data ta 'l-awtorizzazzjoni:

1971-06-01

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ġermaniż 01-07-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Franċiż 01-07-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Franċiż 01-07-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Olandiż 01-07-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Olandiż 01-07-2022

Fittex twissijiet relatati ma 'dan il-prodott